Proprietary AI analyst is now available
- Public Comps
- Ambu
Ambu Valuation Multiples
Discover Ambu's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Carl Zeiss Meditec, TransMedics, Double Medical Technology, Autobio Diagnostics and more.
Ambu Overview
About Ambu
Ambu AS provides medical technology solutions. The company’s business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
Founded
1937
HQ

Employees
5.0K
Website
Financials (LTM)
EV
$3B
Valuation Multiples
Start free trialAmbu Financials
Ambu reported last 12-month revenue of $977M and EBITDA of $178M.
In the same LTM period, Ambu generated $591M in gross profit, $178M in EBITDA, and $94M in net income.
Revenue (LTM)
Ambu P&L
In the most recent fiscal year, Ambu reported revenue of $931M and EBITDA of $178M.
Ambu is profitable as of last fiscal year, with gross margin of 60%, EBITDA margin of 19%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
Ambu Stock Performance
Ambu has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
Ambu's stock price is $10.03.
Ambu share price decreased by 4.7% in the last 30 days, and by 34.7% in the last year.
Ambu has an EPS (earnings per share) of $0.36.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | 1.0% | -4.7% | -7.2% | -34.7% | $0.36 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAmbu Valuation Multiples
Ambu trades at 2.7x EV/Revenue multiple, and 14.7x EV/EBITDA.
EV / Revenue (LTM)
Ambu Financial Valuation Multiples
As of June 10, 2026, Ambu has market cap of $3B and EV of $3B.
Ambu has a P/E ratio of 28.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ambu Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Ambu Margins & Growth Rates
Ambu grew revenue by 7% but EBITDA decreased by 0% in the last fiscal year.
In the most recent fiscal year, Ambu reported gross margin of 60%, EBITDA margin of 19%, and net margin of 10%.
Ambu Margins
Ambu Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Ambu Operational KPIs
Ambu's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Ambu's Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ambu's Rule of X is 39% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Ambu Competitors
Ambu competitors include Carl Zeiss Meditec, TransMedics, Double Medical Technology, Autobio Diagnostics, Sinbon Electronics, Tecan Group, MGI Tech, Establishment Labs, Insight Lifetech and Integer Holdings.
Most Ambu public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.1x | 1.1x | 6.5x | 7.4x | |||
| 4.9x | 4.5x | 18.3x | 18.8x | |||
| 6.0x | 5.6x | 16.6x | 14.0x | |||
| 3.8x | 3.7x | 9.4x | 9.6x | |||
| 2.5x | 2.3x | 16.8x | 18.4x | |||
| 2.1x | 2.1x | 13.5x | 13.5x | |||
| 6.2x | 5.9x | 107.2x | 74.3x | |||
| 12.1x | 10.8x | (179.3x) | (9436.9x) | |||
This data is available for Pro users. Sign up to see all Ambu competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Ambu
Ambu has acquired 2 companies to date.
Last acquisition by Ambu was on October 25th 2017. Ambu acquired invendo medical for $243M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Ambu
| Description | invendo medical is a Germany-based developer of disposable, flexible endoscopy products for gastroenterology procedures. The company targets improvements in patient compliance to boost procedure volumes by prioritizing maneuverability over optical enhancements alone. invendo medical distributes single-use endoscopes designed for enhanced usability in diagnostic and therapeutic applications across global markets. | - |
| HQ Country | ||
| HQ City | Kissing | Misgav |
| Deal Date | 25 Oct 2017 | 23 Jun 2016 |
| Valuation | $243M | $16M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Ambu acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ambu
| When was Ambu founded? | Ambu was founded in 1937. |
| Where is Ambu headquartered? | Ambu is headquartered in Denmark. |
| How many employees does Ambu have? | As of today, Ambu has over 5K employees. |
| Is Ambu publicly listed? | Yes, Ambu is a public company listed on Nasdaq Copenhagen. |
| What is the stock symbol of Ambu? | Ambu trades under AMBU B ticker. |
| When did Ambu go public? | Ambu went public in 1993. |
| Who are competitors of Ambu? | Ambu main competitors include Carl Zeiss Meditec, TransMedics, Double Medical Technology, Autobio Diagnostics, Sinbon Electronics, Tecan Group, MGI Tech, Establishment Labs, Insight Lifetech, Integer Holdings. |
| What is the current market cap of Ambu? | Ambu's current market cap is $3B. |
| What is the current revenue of Ambu? | Ambu's last 12 months revenue is $977M. |
| What is the current revenue growth of Ambu? | Ambu revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Ambu? | Current revenue multiple of Ambu is 2.7x. |
| What is the current EBITDA of Ambu? | Ambu's last 12 months EBITDA is $178M. |
| What is Ambu's EBITDA margin? | Ambu's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Ambu? | Current EBITDA multiple of Ambu is 14.7x. |
| What is the current FCF of Ambu? | Ambu's last 12 months FCF is $74M. |
| What is Ambu's FCF margin? | Ambu's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Ambu? | Current FCF multiple of Ambu is 35.3x. |
| How many companies Ambu has acquired to date? | As of June 2026, Ambu has acquired 2 companies. |
| What was the largest acquisition by Ambu? | $243M acquisition of invendo medical on 25th October 2017 was the largest M&A Ambu has done to date. |
| What companies Ambu acquired? | Ambu acquired invendo medical and ETView Medical. |
| In how many companies Ambu has invested to date? | Ambu hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Ambu
Lists including Ambu
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

